Stocks and Investing Stocks and Investing
Fri, November 13, 2020
Thu, November 12, 2020

Joseph Schwartz Maintained (ASND) at Buy with Increased Target to $191 on, Nov 12th, 2020


Published on 2024-10-27 14:45:30 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of SVB Leerink, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $173 to $191 on, Nov 12th, 2020.

Joseph has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Increased Target to $194 on, Tuesday, October 13th, 2020
Contributing Sources